Join
Live feed
·
PRReleasevia Quantisnow
Surrozen Inc. logo

Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

ByQuantisnow·Wall Street's wire, on your screen.
SRZN· Surrozen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRZN (Surrozen Inc.) and more on Quantisnow.